Augusta Hall
Family · Liberty, SCNPI 1265864235
Payments from drug & device makers
Across 254 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$797
- GSK$587
- AstraZeneca$580
- Novo Nordisk$524
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$182
- AbbVie$181
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 57 | $797 |
| GSK | 37 | $587 |
| AstraZeneca | 29 | $580 |
| Novo Nordisk | 35 | $524 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $182 |
| AbbVie | 10 | $181 |
| Dexcom, Inc. | 9 | $155 |
| Ironshore Pharmaceuticals Inc. | 3 | $134 |
| Boehringer Ingelheim | 8 | $114 |
| Novartis | 7 | $109 |
| Exact Sciences | 7 | $106 |
| Amgen | 4 | $89 |
| Abbott | 4 | $88 |
| Pfizer | 5 | $88 |
| Bayer | 5 | $82 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Edwards Lifesciences | 1 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Insmed, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Shield Therapeutics Inc | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Merck | 1 | $12 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JORNAY PM$120
How this compares
$4,179 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 79 | $82,089 |
| OzempicSemaglutide | 66 | $63,129 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $36,180 |
| FarxigaDapagliflozin Propanediol | 49 | $33,877 |
| RybelsusSemaglutide | 16 | $25,110 |
| TrulicityDulaglutide | 25 | $24,081 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $20,929 |
| JanuviaSitagliptin Phosphate | 23 | $20,672 |
| JardianceEmpagliflozin | 23 | $19,816 |
| EliquisApixaban | 27 | $19,715 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $16,266 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $7,314 |
| Novolog FlexpenInsulin Aspart | 21 | $5,623 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,642 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 143 | $3,953 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $797 | $106,169104 claims |
| Novo NordiskOzempic, Rybelsus | $524 | $88,23882 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $587 | $40,82256 claims |
| AstraZenecaFarxiga | $580 | $33,87749 claims |
| MerckJanuvia | $12 | $20,67223 claims |
| Boehringer IngelheimJardiance | $114 | $19,81623 claims |
| PfizerEliquis | $88 | $19,71527 claims |
| AbbVieSynthroid | $181 | $1,59316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Liberty
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.